A detailed history of Christensen, King & Associates Investment Services, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Christensen, King & Associates Investment Services, Inc. holds 2,614 shares of ABT stock, worth $307,824. This represents 0.14% of its overall portfolio holdings.

Number of Shares
2,614
Previous 2,612 0.08%
Holding current value
$307,824
Previous $271 Million 9.8%
% of portfolio
0.14%
Previous 0.13%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$100.07 - $118.13 $200 - $236
2 Added 0.08%
2,614 $298 Million
Q2 2024

Aug 08, 2024

BUY
$100.73 - $112.44 $201 - $224
2 Added 0.08%
2,612 $271 Million
Q1 2024

Aug 08, 2024

BUY
$109.52 - $120.96 $219 - $241
2 Added 0.08%
2,610 $297 Million
Q4 2023

Aug 08, 2024

BUY
$90.19 - $110.4 $235,215 - $287,923
2,608 New
2,608 $287 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Christensen, King & Associates Investment Services, Inc. Portfolio

Follow Christensen, King & Associates Investment Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Christensen, King & Associates Investment Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Christensen, King & Associates Investment Services, Inc. with notifications on news.